Global Clinical Risk Grouping Solutions Market, Size, Trends, By Product (Data Visualization Tools and Data Analytics), By Deployment (Private Cloud, Public Cloud, and Hybrid Cloud), By End User (Healthcare service providers and Healthcare payers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Clinical Risk Grouping Solutions Market
The Global Clinical Risk Grouping Solutions Market was valued at US$ 0.5 Bn in 2022, estimated to reach US$ 1.5 Bn by 2030, with a CAGR of 12.13% from 2023-2030.
A computer program called clinical risk grouping (CRG) uses expert clinical logic to divide each patient into a particular risk group. It is a specific grouping method structured by data and based on clinical evidence and applies a wide variety of data including patient history, records, administrative data, and other data to identify persons of various age groups including children, adults, and old ones. CRGs are largely used to track chronic or congenital disease prevalence, profile medical practice patterns, profile physician utilization patterns, profile novel disease patterns and occurrences, and many more purposes. CRGs are population-inclusive, patient-centered, and focus on the whole burden of diseases rather than just one particular condition.
Market Drivers
The main factors influencing market expansion include a growing emphasis on patient risk management and the use of big data in the healthcare sector to improve clinical results. The desire for an efficient solution, such as clinical risk grouping, is being driven by the expanding patient pool data collected in healthcare settings, which is increasing the physician burden.
Furthermore, one of the key factors driving the market growth is the accessibility of cutting-edge healthcare information technologies for the wireless monitoring and treatment of patients with various chronic diseases, including blood pressure, heart rate, and diabetes. Chronic diseases can be managed and avoided from becoming severe with the aid of telehealth and telemedicine solutions, as well as healthcare information technology (IT).
Market Restraints
Concerns about patient data protection and a lack of infrastructure are anticipated to limit industry expansion during the forecast period. The lack of qualified healthcare IT workers is likely to challenge the clinical risk grouping solutions market in the forecast period.
Market Segmentation
The scope of the Global Clinical Risk Grouping Solutions Market covers segmentation based on Product Type, Formulation, Therapeutic Area, and Region.
Based on the Product, the market is bifurcated into Data Visualization Tools and Data Analytics.
Based on Deployment, the market is divided into Private Cloud, Public Cloud, and Hybrid Cloud.
Based on End User, the market is classified into Healthcare service providers and Helthcare payers.
Regional Analysis
The Global Clinical Risk Grouping Solutions Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America is anticipated to have significant market expansion during the forecast period. This growth is due to the rising incidence of chronic diseases, the well-established healthcare system, the widespread use of cutting-edge technologies, and government measures to make the upkeep of health data mandatory.
A large pool of patient populations, a growing demand for better risk management solutions, the adoption of recording and maintaining health records, and the rising prevalence of chronic diseases are all factors that point to the Asia Pacific region as having lucrative market growth opportunities.
Key Players
Cerner corporation, Microsoft corporation, Alibaba Group Holding Limited, IBM, Dundas Data Visualization, Inc, SAS, Klipfolio, Oracle Inc., Domo, Inc., Koch Industries, Qlik Technologies, Salesforce, SAP, Sisense, TIBCO, and Greenway.
Market Taxonomy
By Product
• Data Visualization Tools
• Data Analytics
By Deployment
• Private Cloud
• Public Cloud
• Hybrid Cloud
By End User
• Healthcare service providers
• Helthcare payers
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Clinical Risk Grouping Solutions Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Clinical Risk Grouping Solutions Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Clinical Risk Grouping Solutions Market, By Product
5.1 Y-o-Y Growth Comparison, By Deployment and Services
5.2 Global Clinical Risk Grouping Solutions Market Share Analysis, By Product
5.3 Global Clinical Risk Grouping Solutions Market Size and Forecast, By Product
5.3.1 Data Visualization Tools
5.3.2 Data Analytics
6 Global Clinical Risk Grouping Solutions Market, By Deployment
6.1 Y-o-Y Growth Comparison, By Deployment
6.2 Global Clinical Risk Grouping Solutions Market Share Analysis, By Deployment
6.3 Global Clinical Risk Grouping Solutions Market Size and Forecast, By Deployment
6.3.1 Private Cloud
6.3.2 Public Cloud
6.3.3 Hybrid Cloud
7 Global Clinical Risk Grouping Solutions Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Clinical Risk Grouping Solutions Market Share Analysis, By End User
7.3 Global Clinical Risk Grouping Solutions Market Size and Forecast, By End User
7.3.1 Healthcare service providers
7.3.2 Healthcare payers
8 Global Clinical Risk Grouping Solutions Market, By Region
8.1 Global Clinical Risk Grouping Solutions Market Share Analysis, By Region
8.2 Global Clinical Risk Grouping Solutions Market Size and Forecast, By Region
8.3 Global Clinical Risk Grouping Solutions Market Trends and Forecast, By Region
9 North America Clinical Risk Grouping Solutions Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Clinical Risk Grouping Solutions Market Share Analysis, By Product
9.3 North America Clinical Risk Grouping Solutions Market Size and Forecast, By Deployment
9.4 North America Clinical Risk Grouping Solutions Market Size and Forecast, By End User
9.5 North America Clinical Risk Grouping Solutions Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Product
9.5.1.2 Market Size and Forecast, By Deployment
9.5.1.3 Market Size and Forecast, By End User
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Product
9.5.2.2 Market Size and Forecast, By Deployment
9.5.2.3 Market Size and Forecast, By End User
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Product
9.5.3.2 Market Size and Forecast, By Deployment
9.5.3.3 Market Size and Forecast, By End User
10 Europe Clinical Risk Grouping Solutions Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Clinical Risk Grouping Solutions Market Share Analysis, By Product
10.3 Europe Clinical Risk Grouping Solutions Market Size and Forecast, By Deployment
10.4 Europe Clinical Risk Grouping Solutions Market Size and Forecast, By End User
10.5 Europe Clinical Risk Grouping Solutions Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Product
10.5.1.2 Market Size and Forecast, By Deployment
10.5.1.3 Market Size and Forecast, By End User
10.5.2 France
10.5.2.1 Market Size and Forecast, By Product
10.5.2.2 Market Size and Forecast, By Deployment
10.5.2.3 Market Size and Forecast, By End User
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Product
10.5.3.2 Market Size and Forecast, By Deployment
10.5.3.3 Market Size and Forecast, By End User
10.5.4. Russia
10.5.4.1 Market Size and Forecast, By Product
10.5.4.2 Market Size and Forecast, By Deployment
10.5.4.3 Market Size and Forecast, By End User
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Product
10.5.5.2 Market Size and Forecast, By Deployment
10.5.5.3 Market Size and Forecast, By End User
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Product
10.5.6.2 Market Size and Forecast, By Deployment
10.5.6.3 Market Size and Forecast, By End User
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Product
10.5.7.2 Market Size and Forecast, By Deployment
10.5.7.3 Market Size and Forecast, By End User
11 Asia Pacific Clinical Risk Grouping Solutions Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Clinical Risk Grouping Solutions Market Share Analysis, By Product
11.3 Asia Pacific Clinical Risk Grouping Solutions Market Size and Forecast, By Deployment
11.4 Asia Pacific Clinical Risk Grouping Solutions Market Size and Forecast, By End User
11.5 Asia Pacific Clinical Risk Grouping Solutions Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Product
11.5.1.2 Market Size and Forecast, By Deployment
11.5.1.3 Market Size and Forecast, By End User
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Product
11.5.2.2 Market Size and Forecast, By Deployment
11.5.2.3 Market Size and Forecast, By End User
11.5.3 India
11.5.3.1 Market Size and Forecast, By Product
11.5.3.2 Market Size and Forecast, By Deployment
11.5.3.3 Market Size and Forecast, By End User
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Product
11.5.4.2 Market Size and Forecast, By Deployment
11.5.4.3 Market Size and Forecast, By End User
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Product
11.5.5.2 Market Size and Forecast, By Deployment
11.5.5.3 Market Size and Forecast, By End User
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Product
11.5.6.2 Market Size and Forecast, By Deployment
11.5.6.3 Market Size and Forecast, By End User
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Product
11.5.7.2 Market Size and Forecast, By Deployment
11.5.7.3 Market Size and Forecast, By End User
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Deployment and Services
11.5.8.2 Market Size and Forecast, By Deployment
11.5.8.3 Market Size and Forecast, By End User
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Product
11.5.9.2 Market Size and Forecast, By Deployment
11.5.9.3 Market Size and Forecast, By End User
12 Latin America Clinical Risk Grouping Solutions Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Clinical Risk Grouping Solutions Market Share Analysis, By Product
12.3 Latin America Clinical Risk Grouping Solutions Market Size and Forecast, By Deployment
12.4 Latin America Clinical Risk Grouping Solutions Market Size and Forecast, By End User
12.5 Latin America Clinical Risk Grouping Solutions Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Product
12.5.1.2 Market Size and Forecast, By Deployment
12.5.1.3 Market Size and Forecast, By End User
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Product
12.5.2.2 Market Size and Forecast, By Deployment
12.5.2.3 Market Size and Forecast, By End User
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Product
12.5.3.2 Market Size and Forecast, By Deployment
12.5.3.3 Market Size and Forecast, By End User
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Product
12.5.4.2 Market Size and Forecast, By Deployment
12.5.4.3 Market Size and Forecast, By End User
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Product
12.5.5.2 Market Size and Forecast, By Deployment
12.5.5.3 Market Size and Forecast, By End User
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Product
12.5.6.2 Market Size and Forecast, By Deployment
12.5.6.3 Market Size and Forecast, By End User
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Product
12.5.7.2 Market Size and Forecast, By Deployment
12.5.7.3 Market Size and Forecast, By End User
13 Middle East Clinical Risk Grouping Solutions Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Clinical Risk Grouping Solutions Market Share Analysis, By Product
13.3 Middle East Clinical Risk Grouping Solutions Market Size and Forecast, By Deployment
13.4 Middle East Clinical Risk Grouping Solutions Market Size and Forecast, By End User
13.5 Middle East Clinical Risk Grouping Solutions Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Product
13.5.1.2 Market Size and Forecast, By Deployment
13.5.1.3 Market Size and Forecast, By End User
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Product
13.5.2.2 Market Size and Forecast, By Deployment
13.5.2.3 Market Size and Forecast, By End User
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Product
13.5.3.2 Market Size and Forecast, By Deployment
13.5.3.3 Market Size and Forecast, By End User
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Product
13.5.4.2 Market Size and Forecast, By Deployment
13.5.4.3 Market Size and Forecast, By End User
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Product
13.5.5.2 Market Size and Forecast, By Deployment
13.5.5.3 Market Size and Forecast, By End User
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Product
13.5.6.2 Market Size and Forecast, By Deployment
13.5.6.3 Market Size and Forecast, By End User
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Cerner corporation
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Microsoft corporation
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Alibaba Group Holding Limited
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 IBM
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Dundas Data Visualization, Inc.
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 SAS
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Klipfolio
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Oracle Inc.
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Domo, Inc.
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Koch Industries
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
